Synthetic study demonstrates solid-phase ring-opening of cyclic sulfamidates on oligo(amidoamine) backbones, indicating a viable route to sequence-defined N-sulfated macromolecules.
The preparation of sequence‐defined macromolecules using cyclic sulfamidates on solid‐phase is outlined. The challenges surrounding an AB+CD approach are described with focus on understanding the formation of ring‐opened side products when using amide coupling reagents. To avoid undesired side product formation, a strategy of iterative ring‐openings of cyclic sulfamidates on solid‐phase is explored. Ring‐opening on primary and secondary amines is successfully reported, generating both linear and branched chain growth. However, attempts to selectively cleave N‐sulfate bearing sp3‐hybridized groups cannot be demonstrated, limiting the overall building block scope for this methodology. Consequently, the active ring‐opening of cyclic sulfamidates on amine‐functionalized oligo(amidoamine) backbones is successfully applied to produce sequence‐defined, N‐sulfated macromolecules.
No takes yet. Share an insight, caveat, or question.
Hill et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: